Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy

Baseline factors identified for the prediction of good responders in patients with end-stage diffuse coronary artery disease undergoing intracoronary CD34+ cell therapy

Abstract Background Treating patients with end-stage diffuse coronary artery disease (EnD-CAD) unsuitable for coronary intervention remains a clinical challenge. They usually express refractory angina and have a high risk of mortality. Although growing data have indicated cell therapy is an alternat...

Full description

Bibliographic Details
Main Authors: Pei-Hsun Sung, Hsin-Ju Chiang, Yi-Chen Li, John Y. Chiang, Chi-Hsiang Chu, Pei-Lin Shao, Fan-Yen Lee, Mel S. Lee, Hon-Kan Yip
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Stem Cell Research & Therapy
Subjects:
CD34+ cell therapy
Good responders
Diffuse coronary artery disease
Refractory angina
Left ventricular ejection fraction
Online Access:http://link.springer.com/article/10.1186/s13287-020-01835-z

Internet

http://link.springer.com/article/10.1186/s13287-020-01835-z

Similar Items